Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,708 total articles
CNX Resources is trading at depressed multiples despite generating roughly $534M in free cash flow and carrying moderate leverage. Management's conservative production stance, a growing RNG tax-credit stream, and a concentrated set of Utica completions set the stage for an earnings beat and multiple expansion. This trade targets a re-rating into th…
Toast turned profitable in 2025 and generated $608M of free cash flow. With roughly $16.9B market cap and an enterprise value that implies ~6x EV/ARR on 2026 guidance, the risk-reward favors a mid-term long while AI product adoption and enterprise expansion re-rate the multiple. Entry $28.00, target $36.00, stop $24.25; horizon mid term (45 trading…
Marvell is trading at fresh 52-week highs after a strategic photonics acquisition and expanding cloud appetite. Strong cash generation, solid ROE, and partnership momentum support a long trade. Valuation is rich but justified if growth sustains; manage risk around stretched technicals and execution.
Nebius is a neocloud infrastructure play that has converted large hyperscaler demand into multi-year contracted backlog. The setup offers asymmetric upside if the company executes on capacity builds and converts contracted revenue into realized billings. Valuation is aggressive today, so the trade leans on event-driven execution: buy into proof poi…
Brookfield Infrastructure (BIPC) owns power, data infrastructure and specialty energy assets that are directly exposed to the multi-year buildout of AI data centers and semiconductor fabs. The company is growing contracted capacity, delivering consecutive distribution increases and generating predictable cash flows. This trade idea outlines a long …
BridgeBio has moved from binary-event biotech to a commercial-stage rare-disease company. Strong long-term Attruby survival data, positive Phase 3 interim results for BBP-418, and a clear regulatory path for infigratinib give the stock asymmetric upside. I am upgrading to Buy with a defined entry at $73.10, a $93.00 target and a $60.00 stop loss on…
Domino's Pizza Group delivered a robust Q1 and now yields 5.65%, making it an attractive income-oriented long. The company's market position, franchise cash flow model and recent operational momentum support a trade that aims to capture dividend income plus capital appreciation while limiting downside with a tight stop.
DocuSign is trading near its 52-week low but shows signs of a structural rebound: a newly launched Intelligent Agreement Management (IAM) product with $350M ARR in 18 months, attractive free cash flow relative to market cap, improving technical momentum, and heavy short interest that could accelerate squeezes on positive news. We reiterate Buy with…
DXC's stock is cheap on traditional metrics (P/E ~5.3, EV/EBITDA ~2.5) and the company produces meaningful free cash flow. Recent leadership signals and sector tailwinds (hybrid cloud, security, sovereign cloud) create a favorable read-across from new hires into sales execution and margin recovery. This trade targets a mid-term rebound toward $15.5…
Blackstone Senior Floating Rate 2027 Term Fund (BSL) is my top BDC/closed-end pick right now: sub-1.0 PB, near $13.08 per share, a monthly distribution and positive technicals create an asymmetric risk/reward for a mid-term buy. I lay out an entry at $13.05, a stop at $12.30 and a target at $14.50 across a 45-trading-day horizon to capture the ex-d…
Rogers (RCI) looks attractively priced on several measures: market cap ~$20.3B, a PE of 3.65 and a 4.34% yield. Management’s messaging at the AGM and the latest annual filing point to improved free cash flow; paired with a recent debt refinancing and a manageable technical setup, this creates a tradeable long setup for the next 45 trading days.
After a period of skepticism, the evidence stacking up around Advanced Micro Devices (AMD) — big AI customer wins, robust free cash flow, low leverage, and clear technical momentum — has me moving from very bearish to confidently bullish for a defined mid-term trade. This idea lays out the entry, stop, targets, catalysts, and risks for a mid-term (…
Starbucks has shown the first clear signs of transaction-led momentum under CEO Brian Niccol. With Q2 FY26 earnings on 04/28/2026 the market is starting to reward operational improvement. This is a structured swing trade that buys that sentiment while protecting against a negative print or renewed China weakness.
After reassessing signals from demand, manufacturing traction and short-covering dynamics, I'm upgrading Intel to a tactical buy into the Q1 print. The balance of catalysts (14A adoption news, AI-driven server demand, and margin recovery) outweighs the near-term risks, but the position should be managed with a strict stop and a defined time horizon…
Beasley Broadcast Group has moved from balance-sheet risk to a potential recovery story after a package of exchange and tender offers plus asset sales that management expects will cut debt roughly in half. With trailing adjusted EBITDA improving, a tiny public float, and sharply higher share price momentum, BBGI offers a high-risk, high-reward swin…
Archrock (AROC) offers a blend of secular demand exposure to natural gas compression and improving capital returns. At $36.43 the stock trades with a mid-teens upside to our near-term target on an EV/EBITDA ~10 and a 2.3% yield. We lay out a precise entry, stop and target along with catalysts and risks.
Microsoft plunged ~10.7% into the close and opened lower on 04/23/2026. The sell-off looks indiscriminate relative to Microsoft's cash generation, profitability, low leverage and stake in AI upside. This trade idea lays out an entry at $422.24, stop at $395.00 and a primary target of $500.00 for a mid-term swing (45 trading days) with clear risk co…
Salesforce looks materially undervalued given its AI product momentum, strong free cash flow (~$14.4B) and light leverage (debt/equity ~0.24). I outline a long trade with entry at $178.00, a $165 stop and a $230 target over a mid-term 45 trading day horizon, plus the setup that would change my view.
CSX reported Q1 results on 04/22/2026 that beat on EPS ($0.43 vs. $0.39) while revenue came in roughly flat at $3.48B. With a 32% operating margin in FY2025, improving intermodal volumes, a rising dividend and disciplined capital allocation, CSX looks positioned for multi-year earnings expansion. This trade idea offers a long entry at $45.35, a pro…
Rogers' rally after its latest earnings release appears driven more by headline relief than by a durable improvement in key operating fundamentals. With limited fresh positive data available, a disciplined short targeting a reversion toward prior trading ranges offers asymmetric risk-reward. This trade uses precise entry, stop and target levels and…
SpaceX’s IPO changes the calculus for independent small-to-medium launch providers. Rocket Lab (RKLB) faces intensified pricing pressure, customer concentration risk, and lost strategic optionality as a vertically integrated SpaceX leverages scale, cadence, and Starship capacity. This trade idea lays out a mid-term (45 trading days) short with conc…
Snowflake reported a strong quarter but face-downside from macro and legal headlines has pushed the stock back toward 52-week lows. Fundamentals and AI-driven demand argue for upside; valuation and a class-action/legal overhang justify a disciplined entry with a clear stop. This trade is a mid-term swing designed to capture mean-reversion into impr…
Anteris Technologies could swing materially higher if DurAVR's PARADIGM program delivers positive clinical and regulatory signals. This trade idea lays out a disciplined long with entry, target and stop, time horizon, catalysts, and the downside scenarios that would invalidate the thesis.
Airbus is benefiting from a surging order book, yet a persistent delivery bottleneck and stretched supply chain are keeping revenue and cash conversion on the sidelines. Technicals and short-interest dynamics suggest an elevated probability of a mid-term pullback. This is a tactical short idea designed to profit from delivery disappointment and sen…
Kraken Robotics (KRKNF) has moved from a small, high-risk developer to a company booking multi-million-dollar repeat contracts and reporting meaningful margin expansion. At a market cap of $1.93B the stock has already priced growth; however, recent wins, a $20M equity raise and a 175% jump in quarterly revenue suggest the business is now materially…
